Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders DOI Creative Commons
Mustafa M Shokr, Ghada A. Badawi,

Shimaa M. Elshazly

et al.

ACS Pharmacology & Translational Science, Journal Year: 2024, Volume and Issue: 8(1), P. 47 - 65

Published: Dec. 30, 2024

Sigma 1 receptor (S1R) is a multifunctional, ligand-activated protein located in the membranes of endoplasmic reticulum (ER). It mediates variety neurological disorders, including epilepsy, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease. The wide neuroprotective effects S1R agonists are achieved by pro-survival and antiapoptotic S1R-mediated signaling functions. Nonetheless, relatively little known about specific molecular mechanisms underlying activity. Many studies on have highlighted importance maintaining normal cellular homeostasis through its control calcium lipid exchange between ER mitochondria, ER-stress response, many other mechanisms. In this review, we will discuss different localization explain S1R-associated biological activity, such as ER-plasma membrane Mitochondrion-Associated Membrane interfaces. While outlining important binding partners involved these processes, also explained how dysregulation pathways contributes to neurodegenerative disorders.

Language: Английский

Exploring Endogenous Tryptamines: Overlooked Agents Against Fibrosis in Chronic Disease? A Narrative Review DOI Creative Commons
Hunter Korsmo

Livers, Journal Year: 2024, Volume and Issue: 4(4), P. 615 - 637

Published: Nov. 28, 2024

Long regarded as illicit substances with no clinical value, N-dimethylated tryptamines—such N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine, and bufotenine—have been found to produce naturally in a wide variety of species, including humans. Known for their psychoactive effects through serotonin receptors (5-HTRs), tryptamines are currently being reinvestigated clinically long-term benefits mental disorders. Endogenous tryptamine is methylated by indolethylamine-N-methyltransferase (INMT), which can then serve an agonist pro-survival pathways, such sigma non-opioid intracellular receptor 1 (SIGMAR1) signaling. Fibrogenic diseases, like metabolic-associated fatty liver disease (MAFLD), steatohepatitis (MASH), chronic kidney (CKD) have shown changes INMT SIGMAR1 activity the progression pathogenesis. At cellular level, endothelial cells fibroblasts express various tissues; however, little known about injury fibrosis. In this review, I will give overview biochemistry, molecular biology, current evidence INMT’s role hepatic fibrogenesis. also discuss pre-clinical findings N-methylated highlight new upcoming therapeutic strategies that may be adapted mitigating fibrogenic diseases. Finally, mention recent mutualistic gut bacteria influencing endogenous signaling metabolism.

Language: Английский

Citations

0

Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders DOI Creative Commons
Mustafa M Shokr, Ghada A. Badawi,

Shimaa M. Elshazly

et al.

ACS Pharmacology & Translational Science, Journal Year: 2024, Volume and Issue: 8(1), P. 47 - 65

Published: Dec. 30, 2024

Sigma 1 receptor (S1R) is a multifunctional, ligand-activated protein located in the membranes of endoplasmic reticulum (ER). It mediates variety neurological disorders, including epilepsy, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease. The wide neuroprotective effects S1R agonists are achieved by pro-survival and antiapoptotic S1R-mediated signaling functions. Nonetheless, relatively little known about specific molecular mechanisms underlying activity. Many studies on have highlighted importance maintaining normal cellular homeostasis through its control calcium lipid exchange between ER mitochondria, ER-stress response, many other mechanisms. In this review, we will discuss different localization explain S1R-associated biological activity, such as ER-plasma membrane Mitochondrion-Associated Membrane interfaces. While outlining important binding partners involved these processes, also explained how dysregulation pathways contributes to neurodegenerative disorders.

Language: Английский

Citations

0